eNeura, Inc. Receives FDA Clearance for Use of SpringTMS(R) for Migraine Prevention
SpringTMS is the only product available to patients in the United States for both acute treatment of migraine and migraine prevention
eNeura to exhibit at the 18th Congress of the International Headache Society (IHC2017)
BALTIMORE, Sept. 7, 2017 -- (... Devices, Neurology, FDA eNeura, eNeura Spring TMS, Transcranial Magnetic Stimulation, migraine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news